Related Experiment Videos
Resource utilization patterns in patients with acquired immunodeficiency syndrome (AIDS)
1Makerere Medical School, Kampala, Uganda.
East African Medical Journal
|December 1, 1994
Summary
Drug costs for acquired immunodeficiency syndrome (AIDS) care in Uganda are alarmingly high, consuming a significant portion of healthcare budgets. Urgent strategies are needed to control these expenses for essential AIDS treatment.
Area of Science:
- Public Health
- Health Economics
- Infectious Diseases
Background:
- The acquired immunodeficiency syndrome (AIDS) epidemic presents a substantial challenge to healthcare systems globally, particularly in resource-limited settings.
- Resource utilization and cost analysis are critical for sustainable management of chronic diseases like AIDS.
Purpose of the Study:
- To investigate resource use patterns and cost factors associated with acquired immunodeficiency syndrome (AIDS) care.
- To analyze the economic impact of essential drug provision for AIDS patients in Uganda.
Main Methods:
- A survey was conducted in 1991 at Mulago Hospital, Kampala, Uganda, to assess resource use and cost factors in AIDS patient care.
- Data collection focused on outpatient and inpatient treatment episodes, specifically quantifying drug expenditures.
Main Results:
- Drugs accounted for 97% of mean care costs for outpatients and 37% for inpatients with AIDS.
- The cost per treatment episode was Ug.Sh.5785.00 for outpatients and Ug.Sh.8309.00 for inpatients (1991 exchange rate: US$1 = Ug.Sh.910.00).
- Essential drug provision for the growing number of AIDS patients could potentially consume Uganda's entire Ministry of Health budget.
Conclusions:
- High drug costs represent a major financial burden in AIDS care in Uganda.
- There is an urgent need to explore and implement cost-control strategies for essential drugs in AIDS management to ensure budget sustainability.
Keywords:
Acquired Immunodeficiency SyndromeAfricaAfrica South Of The SaharaDelivery Of Health CareDeveloping CountriesDiseasesDrugs--costEastern AfricaEconomic FactorsEnglish Speaking AfricaExpendituresFinancial ActivitiesHealthHealth FacilitiesHiv InfectionsHospitalsResource AllocationTreatment--costUgandaViral Diseases